Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
12/20/1998 | CA2241117A1 Herbal anti-diabetic therapeutic product |
12/18/1998 | CA2239605A1 Novel g-protein coupled receptor (h7tba62) |
12/17/1998 | WO1998056898A2 Human peroxisomal thioesterase |
12/17/1998 | WO1998056820A1 Hm74a receptor |
12/17/1998 | WO1998056814A1 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases |
12/17/1998 | WO1998056788A1 Imidazolyl-cyclic acetals |
12/17/1998 | WO1998056787A1 4-Phenylpiperidine compounds |
12/17/1998 | WO1998056406A1 Stable insulin formulations |
12/17/1998 | WO1998056378A1 Novel niddm regimen |
12/17/1998 | WO1998056377A1 Novel pyrazole and pyrazoline substituted compounds |
12/17/1998 | WO1998056376A1 Novel heteroaryl compounds for the modulation of protein tyrosine enzyme related cellular signal transduction |
12/17/1998 | WO1998030586A3 Diagnostics and therapy of epstein-barr virus in autoimmune disorders |
12/17/1998 | DE19725391A1 Verfahren zur Herstellung von Arzneimittel, enthaltend HMG-CoA-Reduktase-Inhibitoren A process for the production of medicaments comprising HMG-CoA reductase inhibitors |
12/17/1998 | CA2294057A1 Novel pyrazole and pyrazoline substituted compounds |
12/17/1998 | CA2293400A1 Novel heteroaryl compounds for the modulation of protein tyrosine enzyme related cellular signal transduction |
12/16/1998 | EP0884387A2 Human 7-transmembrane receptor HLWAR77 |
12/16/1998 | EP0884386A1 Sodium channel receptor |
12/16/1998 | EP0884321A1 Ascorbic acid 2-phosphate zinc salt and process for manufacturing the same |
12/16/1998 | EP0884053A1 Stable insulin formulations |
12/16/1998 | EP0884052A1 Cartilage/bone inducing materials for reparation |
12/16/1998 | EP0884050A1 Use of 3,4-dihydroxy-2-hydroxymethylpyrrolidine for the treatment of diabetes |
12/16/1998 | EP0883406A1 Use of il-7 for treating auto-immune diseases and insulin-dependent diabetes mellitus in particular |
12/16/1998 | EP0883404A1 Combination therapy for osteoporosis |
12/16/1998 | EP0883401A1 At1 receptor antagonist for the stimulation of apoptosis |
12/16/1998 | EP0696585B1 Novel bisoxadiazolidine derivative |
12/16/1998 | CN1202107A Selective 'beta'3 adrenergic agonists |
12/16/1998 | CN1202106A Selective 'beta'3 adrenergic agonists |
12/16/1998 | CN1202105A 2-alkylpyrrolidines |
12/16/1998 | CN1041203C Preparation of pyrazolopyridine compound |
12/15/1998 | US5849930 Pyrazolidine derivative radical scavenger brain-infarction depressant and brain-edema depressant |
12/15/1998 | US5849865 Peptides for altering bone resorption, angiogenesis and restenosis |
12/15/1998 | US5849794 Guanylhydrazones and their use to treat inflammatory conditions |
12/15/1998 | US5849787 Hypercholesterolemia therapeutic agent |
12/15/1998 | US5849781 Tricyclic amides |
12/15/1998 | US5849751 Amides and sulphonamides of benzylamines having heterocyclic substituents |
12/15/1998 | US5849749 6-(hydroxymethyl-ethyl)pyridines |
12/15/1998 | US5849740 Methods for using ketoconazole and related substances in medicaments for treatment of type II diabetes |
12/15/1998 | US5849739 5-arylindole derivatives |
12/15/1998 | US5849736 Isoxazoline and isoxazole fibrinogen receptor antagonists |
12/15/1998 | US5849708 Promotion of eating behavior |
12/15/1998 | US5849584 Cell cultures of and cells culturing method for nontransformed parotid cells |
12/15/1998 | US5849535 Human growth hormone variants |
12/15/1998 | US5849506 Reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome |
12/15/1998 | US5849485 Liver enriched transcription factor |
12/15/1998 | US5849283 Human interleukin-6 receptor antagonists |
12/15/1998 | CA2101274C Microbial oil mixtures and uses thereof |
12/15/1998 | CA1340246C Use of pyridoxine derivatives in the prevention and treatment of hyperlipidaemia and athersclerosis |
12/13/1998 | CA2240312A1 .beta.-adrenergic agonists to reduce a wasting condition |
12/11/1998 | CA2233584A1 7tm receptor hlwar77 |
12/11/1998 | CA2230998A1 Cdna clone hapoi67 that encodes a human 7-transmembrane receptor |
12/10/1998 | WO1998055622A1 Preparation of glycosylated tumor necrosis factor |
12/10/1998 | WO1998055483A1 PYRROLO[2,1,5-cd]INDOLIZINE DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
12/10/1998 | WO1998055475A1 Guanidine deriviatives as inhibitors of na+/h+ exchange in cells |
12/10/1998 | WO1998055144A1 Methods for treating obesity |
12/10/1998 | WO1998055139A1 Use of leptin antagonists for the treatment of diabetes |
12/10/1998 | WO1998055123A1 Antagonists of gonadotropin releasing hormone |
12/10/1998 | WO1998055122A1 Composition comprising 5-[4-[2-(n-methyl-n-2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione |
12/10/1998 | WO1998055121A1 Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome and gestational diabetes |
12/10/1998 | WO1998054981A1 Method for administering viable microorganism composition for poultry |
12/10/1998 | WO1998035967A3 Biazacyclic crf antagonists |
12/10/1998 | CA2333352A1 Composition comprising 5-¬4-¬2-(n-methyl-n-2-pyridyl)amino)ethoxy|benzyl|thiazolidine-2,4-dione |
12/10/1998 | CA2293504A1 Use of leptin antagonists for the treatment of diabetes |
12/10/1998 | CA2292880A1 Antagonists of gonadotropin releasing hormone |
12/10/1998 | CA2289564A1 Preparation of glycosylated tumor necrosis factor |
12/10/1998 | CA2283319A1 Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome and gestational diabetes |
12/10/1998 | CA2234411A1 Novel compounds |
12/09/1998 | EP0882793A2 A human 7-tm receptor similar to murine frizzled-6 gene |
12/09/1998 | EP0882737A1 Ligated d-protein and method of indentifying compounds that modulate receptor activity |
12/09/1998 | EP0882718A1 Benzimidazole derivatives |
12/09/1998 | EP0882707A1 Novel tricyclic compounds and drug compositions containing the same |
12/09/1998 | EP0882450A2 Cholesterol-lowering composition comprising coenzyme Q |
12/09/1998 | EP0882029A1 Heterocyclic derivatives as antidiabetic and antiobesity agents |
12/09/1998 | EP0810866A4 Use of acid-sensitive organo- transition metal compounds in cancer treatment |
12/09/1998 | CN1201458A (-) cis-6(S)-phenyl-5(R)-[4-(2-pyrrolidin-1-ylethoxy) phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol D-tartrate |
12/09/1998 | CN1201455A Process and intermediates for preparing 1-(2-[2-isoxazol-3-ylbenzofuran-5-yloxy] ethylamino)-3-phenoxy-2(S)-ol |
12/09/1998 | CN1201397A Improved prescription for steroid compound administration |
12/09/1998 | CN1201392A Pentacyclic compounds, intermediates, preparation process, compositions and methods thereof |
12/09/1998 | CN1200933A Traditional Chinese medicinal composition with reducing-blood-sugar activity |
12/08/1998 | US5847004 Method for in vivo reduction of nitric oxide levels and compositions useful therefor |
12/08/1998 | US5847000 Fatty acid derivatives |
12/08/1998 | US5846988 Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents |
12/08/1998 | US5846968 N-substituted azaheterocyclic carboxylic acids and esters |
12/08/1998 | US5846966 Combinations of hydroxy-substituted azetidinone compounds and HMG CoA Reductase Inhibitors |
12/08/1998 | US5846962 Anti-obesity agents |
12/08/1998 | CA2026671C 24-homo vitamin d derivatives, process for their production and pharmaceutical preparations obtained therefrom |
12/08/1998 | CA1340171C Aqueous solution conataing fat-soluble vitamin k |
12/03/1998 | WO1998054572A1 Methods for evaluating tissue morphogenesis and activity |
12/03/1998 | WO1998054316A1 Sodium channel receptor |
12/03/1998 | WO1998054220A1 PGC-1, A NOVEL BROWN FAT PPARη COACTIVATOR |
12/03/1998 | WO1998054216A1 Gene and amino acid sequences for novel transcription factor |
12/03/1998 | WO1998054212A2 Human type 3 ryanodine receptor protein and dna molecules coding therefor |
12/03/1998 | WO1998054184A1 1,6-naphthyridine anti-convulsants |
12/03/1998 | WO1998054181A1 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors |
12/03/1998 | WO1998054166A1 A new salt |
12/03/1998 | WO1998054153A1 Novel cyclic diamine compounds and medicine containing the same |
12/03/1998 | WO1998054138A1 Novel orally active iron (iii) chelators |
12/03/1998 | WO1998053847A1 Transdermal delivery system |
12/03/1998 | WO1998053846A1 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
12/03/1998 | WO1998053824A1 Novel process |
12/03/1998 | WO1998053823A1 5-HT1A AND 5-HT1Dα ANTAGONISTS |